SR9009 (Stenabolic) Abstract

A new drug known as SR9009, which is presently under development at TSRI (The Scripps Research Institute) has been shown to considerably boost exercise endurance in animal models.Scientists think these discoveries may lead to improved cures for individuals suffering from illnesses that severely limit exercise endurance such as obesity, COPD (chronic obstructive pulmonary disease), congestive heart failure and also in the deterioration of muscle capacity linked with aging.

The drug was developed by Professor Thomas Burris who found that it was capable of reducing obesity in animal models, particularly mice. SR9009 which is an easy to dose oral compound can increase the level of metabolic activity in skeletal muscle of mice. The treated mice became lean,developed larger muscles and had a 50% increase in running abilities which imitates the effects of aerobic exercise.

SR9009, which is currently under development at The Scripps Research Institute (TSRI),increases the level of metabolic activity in skeletal muscles of mice. Treated mice become lean,develop larger muscles and can run much longer distances simply by taking SR9009, which mimics the effects of aerobic exercise. If similar effects can be obtained in people, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes might be the very welcome result.​

SR9009 (Stenabolic) Applications

Stenabolic has the ability to alter the activity of the skeletal muscle mitochondria, or in simple terms – it boosts your metabolic activity. This makes it similar to what DNP does, being SR9009 much safer and not counter productive to your endurance goals. What’s more, unlike DNP,SR9009 has the ability to mimic actual aerobic exercise without actually putting in the conditioning. Therefore, it will boost your endurance instead of hurting it.Stenabolic (SR9009) binds to a protein called Rev-erbA. This is important, as this protein influences fat and sugar burning in the liver, production of fat cells, and the body’s inflammatory responses. As a result, this interaction between SR9009 and Rev-erbA allows you to make your current exercise regiment much more effective. In fact, even sitting on your butt all day will not hinder your objectives. All in all, the ultimate goal is to burn off for energy from what you eat,instead of getting it stored as fat, which SR does great. Furthermore, it will attack the existing fat and burn it off.

Stenabolic (SR9009) will help a person become leaner, and it will help them do more distance with cardio without getting winded as fast. Overall, it will increase your VO2 max, allowing you to improve your endurance.

Additionally, SR9009 can benefit non athletes as well, since it can reverse obesity, metabolic syndrome, and type 2 diabetes.